StockVS

NYSE · Household & Personal Products · USD

Nu Skin Enterprises, Inc. (NUS) Stock Analysis

Nu Skin Enterprises, Inc. (NUS) is a Household & Personal Products stock listed on NYSE and quoted in US Dollar.

NUS

$4.84

+$0.14 (+2.98%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare NUS with… →

NUS Key Statistics

As of Sep 4, 2026
Trading
Open
$4.69
Previous Close
$4.70
Day's Range
4.67–4.87
52-Week Range
4.49–14.62
Volume
390.40K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
0.96
Valuation
Market Cap
$235.59M
P/E Ratio
unprofitable
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
4.17
PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
0.78
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
0.17
EPS (ttm)Profit attributable to each share over the last twelve months.
−4.53
Financials (FY)
Revenue (FY)
$1.49B−14.26%
Net Income (FY)
$160.20M
Profit marginThe share of revenue left as profit after all costs and taxes.
−15.73%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
48.68M
1-Year Return
−59.74%
Dividend and dates
Dividend
$0.24+5.11%
Ex-Dividend Date
August 28, 2026
Earnings Date
November 5, 2026estimated
Avg Volume
671.65K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

NUS Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−48.82%
2025+43.29%
2024−63.67%
2023−51.07%
2022−13.92%
2021−4.32%
2020+38.68%
2019−30.98%
2018−8.32%
2017+46.55%
2016 (partial year)−17.75%

As of September 4, 2026.

NUS Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$1.49B$160.20M10.8%
2024$1.73B−$146.59M−8.5%
2023$1.97B$8.60M0.4%
2022$2.23B$104.78M4.7%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$1.49B$1.03B$90.88M$160.20M10.8%
2024$1.73B$1.18B$50.78M−$146.59M−8.5%
2023$1.97B$1.36B$68.06M$8.60M0.4%
2022$2.23B$1.59B$159.34M$104.78M4.7%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

NUS Dividend History

$0.24+0.0% vs 2024

Dividends per share, 2025 · 4 payments

YearDividends per sharePaymentsChange
2026*$0.122
2025$0.244+0.0%
2024$0.244−84.6%
2023$1.564+1.3%
YearDividends per sharePaymentsChange
2026 (partial year)$0.122
2025$0.244+0.0%
2024$0.244−84.6%
2023$1.564+1.3%
2022$1.544+1.3%
2021$1.524+1.3%
2020$1.504+1.4%
2019$1.484+1.4%
2018$1.464+1.4%
2017$1.444+305.6%
2016$0.361

Most recent payment: $0.06 per share, ex-dividend May 29, 2026. Per-share amounts summed by calendar year from ex-dividend dates. Partial years are shown muted and marked with an asterisk.

NUS Valuation vs Household & Personal Products Median

Median of 33 stocks
MetricNUSHousehold & Personal Products medianvs median
P/S ratio0.171.080.2x the median
Profit margin−15.73%0.00%15.7 pts below

Medians across 33 Household & Personal Products stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

Nu Skin Enterprises, Inc. (NUS) carries a market capitalisation of $235.59M. The company sits in the Consumer Defensive sector, in the Household & Personal Products industry. Headcount on file is 2,800.

The 52-week range on file runs from $4.49 to $14.62. The most recent close on file for NUS is $4.84, dated September 4, 2026. That is +$0.14 (+2.98%) against the previous close. The latest close sits 7.8% above that 52-week low.

Financial Health

In fiscal 2025, Nu Skin Enterprises, Inc. reported revenue of $1.49B. That is −14.26% against the prior fiscal year, when revenue was $1.73B. Net income for the same year was $160.20M. The reported profit margin is −15.74%. That is 15.7 percentage points below the Household & Personal Products median of 0%. Trailing earnings per share are −4.53.

Across the 4 fiscal years on file, revenue moves from $2.23B in 2022 to $1.49B in 2025. Of those 4 years, 3 report positive net income.

Valuation Assessment

The record shows negative trailing earnings, so no price-to-earnings ratio is published. On forward earnings the ratio is 4.17. The PEG ratio, which sets the P/E against expected earnings growth, reads 0.78. Measured against sales, the shares trade at 0.17 times revenue. On price-to-sales that is 0.2 times the Household & Personal Products median of 1.08. 33 Household & Personal Products companies report these metrics, and the medians quoted come from that group.

Over the trailing twelve months the price has returned −59.74%. Across 10 years the annualized return works out at −19.61%. The reported beta is 0.96. Daily returns over the trailing 10 years annualize to a volatility of 49.18%.

Growth & Income

NUS pays a dividend yielding 5.11%. That is 2 percentage points above the Household & Personal Products median yield of 3.13%. The indicated annual rate is $0.24 a share. The ex-dividend date on file is August 28, 2026. Dividends are recorded for 11 calendar years; 2026 shows 2 payments totalling $0.12 a share. The year before, 2025, totalled $0.24 a share.

Across the complete calendar years on file, 2017 returned +46.55% and 2024 returned −63.67%. Of the 9 complete calendar years on file, 3 finished higher. So far in 2026 the price is −48.82%.

Peer Comparison

Nu Skin Enterprises, Inc. (NUS) operates in the Household & Personal Products industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Nu Skin Enterprises, Inc. NUS $235.59M
The Procter & Gamble Company PG $340.13B 22.1
Unilever PLC UL $138.24B 21.8
Colgate-Palmolive Company CL $70.77B 35.0

The Household & Personal Products industry average P/E ratio is 22.1x. Nu Skin Enterprises, Inc. has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Household & Personal Products Stocks

View all Household & Personal Products stocks →

Popular Consumer Defensive Stocks

View all Consumer Defensive stocks →

About Nu Skin Enterprises, Inc.

Nu Skin Enterprises, Inc., together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa, ageLOC LumiSpa iO, and Nu Skin RenuSpa iO; ageLOC TruFace and ageLOC LumiSpa cleansers and devices; Prysm iO, a data-enabled wellness device; and Nutricentials beauty and Beauty Focus wellness brands. The company also provides wellness products, such as ageLOC TRME, LifePak, and Beauty Focus. In addition, it is the research and product development of skin care products, nutritional supplements, and devices. The company sells its products under the Nu Skin, Pharmanex, and ageLOC brands through retail stores, website, digital platforms, and independent direct sellers and marketers, as well as a service center and independent marketers. It serves Mainland China; South Korea; Southeast Asia/Pacific, which includes Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Australia, New Zealand and other markets; Americas, comprising Canada, Latin America and the United States; Japan; Hong Kong/Taiwan, consists of Macau; and Europe & Africa, which includes markets in Europe as well as South Africa. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.

Visit website →